Cargando…
“Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial
(1) Background: Arteriosclerosis is associated with high levels of low-density lipoprotein (LDL) cholesterol. O-methylated catechins in “Benifuuki” green tea are expected to reduce cholesterol levels, although there is limited research regarding this topic; (2) Methods: This trial evaluated 159 heal...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073342/ https://www.ncbi.nlm.nih.gov/pubmed/30029523 http://dx.doi.org/10.3390/nu10070924 |
_version_ | 1783344168119042048 |
---|---|
author | Miyawaki, Masahiro Sano, Hiroyuki Imbe, Hisashi Fujisawa, Reiko Tanimoto, Keiji Terasaki, Jungo Maeda-Yamamoto, Mari Tachibana, Hirofumi Hanafusa, Toshiaki Imagawa, Akihisa |
author_facet | Miyawaki, Masahiro Sano, Hiroyuki Imbe, Hisashi Fujisawa, Reiko Tanimoto, Keiji Terasaki, Jungo Maeda-Yamamoto, Mari Tachibana, Hirofumi Hanafusa, Toshiaki Imagawa, Akihisa |
author_sort | Miyawaki, Masahiro |
collection | PubMed |
description | (1) Background: Arteriosclerosis is associated with high levels of low-density lipoprotein (LDL) cholesterol. O-methylated catechins in “Benifuuki” green tea are expected to reduce cholesterol levels, although there is limited research regarding this topic; (2) Methods: This trial evaluated 159 healthy volunteers who were randomized to receive ice cream containing a high-dose of “Benifuuki” extract including 676 mg of catechins (group H), a low-dose of “Benifuuki” extract including 322 mg of catechins (group L), or no “Benifuuki” extract (group C). Each group consumed ice cream (with or without extract) daily for 12 weeks, and their lipid-related parameters were compared; (3) Results: A significant reduction in the level of lectin-like oxidized LDL receptor-1 ligand containing ApoB (LAB) was detected in group H, compared to groups L and C. No significant differences between the three groups were detected in their levels of total cholesterol, triglycerides, and LDL cholesterol; (4) Conclusions: “Benifuuki” extract containing O-methylated catechins may help prevent arteriosclerosis. |
format | Online Article Text |
id | pubmed-6073342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60733422018-08-13 “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial Miyawaki, Masahiro Sano, Hiroyuki Imbe, Hisashi Fujisawa, Reiko Tanimoto, Keiji Terasaki, Jungo Maeda-Yamamoto, Mari Tachibana, Hirofumi Hanafusa, Toshiaki Imagawa, Akihisa Nutrients Article (1) Background: Arteriosclerosis is associated with high levels of low-density lipoprotein (LDL) cholesterol. O-methylated catechins in “Benifuuki” green tea are expected to reduce cholesterol levels, although there is limited research regarding this topic; (2) Methods: This trial evaluated 159 healthy volunteers who were randomized to receive ice cream containing a high-dose of “Benifuuki” extract including 676 mg of catechins (group H), a low-dose of “Benifuuki” extract including 322 mg of catechins (group L), or no “Benifuuki” extract (group C). Each group consumed ice cream (with or without extract) daily for 12 weeks, and their lipid-related parameters were compared; (3) Results: A significant reduction in the level of lectin-like oxidized LDL receptor-1 ligand containing ApoB (LAB) was detected in group H, compared to groups L and C. No significant differences between the three groups were detected in their levels of total cholesterol, triglycerides, and LDL cholesterol; (4) Conclusions: “Benifuuki” extract containing O-methylated catechins may help prevent arteriosclerosis. MDPI 2018-07-19 /pmc/articles/PMC6073342/ /pubmed/30029523 http://dx.doi.org/10.3390/nu10070924 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Miyawaki, Masahiro Sano, Hiroyuki Imbe, Hisashi Fujisawa, Reiko Tanimoto, Keiji Terasaki, Jungo Maeda-Yamamoto, Mari Tachibana, Hirofumi Hanafusa, Toshiaki Imagawa, Akihisa “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial |
title | “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial |
title_full | “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial |
title_fullStr | “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial |
title_full_unstemmed | “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial |
title_short | “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial |
title_sort | “benifuuki” extract reduces serum levels of lectin-like oxidized low-density lipoprotein receptor-1 ligands containing apolipoprotein b: a double-blind placebo-controlled randomized trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073342/ https://www.ncbi.nlm.nih.gov/pubmed/30029523 http://dx.doi.org/10.3390/nu10070924 |
work_keys_str_mv | AT miyawakimasahiro benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial AT sanohiroyuki benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial AT imbehisashi benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial AT fujisawareiko benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial AT tanimotokeiji benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial AT terasakijungo benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial AT maedayamamotomari benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial AT tachibanahirofumi benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial AT hanafusatoshiaki benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial AT imagawaakihisa benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial |